comparemela.com

Latest Breaking News On - Investigational new drug application - Page 12 : comparemela.com

Atara Biotherapeutics Announces Submission of Investigational New Drug Application for ATA3219 for Treatment of Lupus Nephritis

Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced its recent.

United statesRajani dinavahiCokey nguyenAtara biotherapeutics incExchange commissionProduct serviceSecurities exchangeDrug administrationInvestigational new drug applicationInvestigational new drugChief medical officerChief scientificTechnical officerSecurities actSecurities exchange actMiddle east

60 Degrees Pharmaceuticals Appoints Kristen Landon as Chief Commercial Officer

To lead U.S. commercial relaunch of ARAKODA® for malaria preventionWill support Company plan to expand clinical research strategy in tick-borne diseases beyond acute babesiosis WASHINGTON,.

United statesGeoff dowPatrick gaynesSheilaa burkeKristen landonGlobenewswire incMateriel development activityFairleigh dickinson universityUnited states armyDegrees pharmaceuticals incAbbott labsKnight therapeutics incCompany typeSilberman college of businessRadius healthWalter reed army institute of research

Biotech stock Tenax Therapeutics more than doubled on Tuesday

Biotech stock Tenax Therapeutics more than doubled on Tuesday
invezz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from invezz.com Daily Mail and Mail on Sunday newspapers.

United kingdomChris giordanoToro united states securities incTenax therapeutic incFinancial conduct authorityInteractive brokersToro united statesTrademark officeFood drug administrationTenax therapeuticsFinancial conductEntry numberDrug administrationInvestigational new drug application

Lexaria submits IND to begin Phase 1b study of DehyraTECH-CBD (NASDAQ:LEXX)

Lexaria submits IND to begin Phase 1b study of DehyraTECH-CBD (NASDAQ:LEXX)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Lexaria dehydraIryna drozdInvestigational new drug application

Considerations for the Development of Chimeric Antigen Receptor (CAR) T Cell Products

This is the draft guidance Considerations for the Development of Chimeric Antigen Receptor (CAR) T Cell Products

Guidance issuing officeOffice of tissuesDrug administrationDocket numberBiologics evaluationAdvanced therapiesInvestigational new drug application

vimarsana © 2020. All Rights Reserved.